CompletedPhase 2

Cord Blood Transplantation in Severe Aplastic Anemia

France26 participantsStarted 2011-05

Plain-language summary

This is a Prospective Phase II Study to evaluate Cord Blood Transplantation in Inherited or Acquired Severe Aplastic Anemia Refractory or in Relapse after Immunosuppressive Therapy in the absence of an HLA identical donor;

Who can participate

Age range3 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age: 3-55 years old * inherited aplastic anemia (with severe aplastic anemia criteria) or acquired aplastic anemia in relapse or treatment failure after immunosuppressive therapy without clonal evolution * Karnovsky Index \>= 60% * Informed consent Exclusion Criteria: * HLA identical donor

What they're measuring

Overall survival

Timeframe: 1 year

Trial details

NCT IDNCT01343953

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-06

View on ClinicalTrials.gov More Hereditary Diseases trials